High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H. Jansson, Kathleen Kelly, Supreet Agarwal et al.|Scientific Reports|2018Cited by 33
Abstract 3065: High-throughput screen identifies HSP90 as a potential therapeutic target in models of advanced CRPCKeith H. Jansson, Kathleen Kelly, John B. Tucker et al.|Cancer Research|2017Cited by 0
Abstract B018: A high-throughput screen identifies HSP90 inhibitors as potent therapeutics across multiple clinically representative organoid models of advanced prostate cancerKeith H. Jansson, Kathleen Kelly, John B. Tucker et al.|Cancer Research|2018Cited by 0